| Application no. and date | 11788263.9 (espacenet) (Federated) (European Patent Register), 20111101 | | Patent/reg. no. and date | DK/EP 2638033, 20150408 | | Publication date | 20130918 | | Priority no. and date | US 411137 P, 20101108 | | EP pub. no. and date |
EP 2638033 20130918 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | P81501269DK00E | | Inventor | JOSEPH, Sajan, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis
Indiana 46206-6288, US,
SAMAJDAR, Susanta, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis
Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4995 (2006.01) , A61P 35/00 (2006.01) , C07D 401/14 (2006.01) | | Title | Forbindelser, der kan anvendes til inhibering af CHK1 | | Int. application no. | US2011058692 | | Int. publication no. | WO2012064548 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
